Page last updated: 2024-10-25

dapsone and Leukoencephalopathy, Progressive Multifocal

dapsone has been researched along with Leukoencephalopathy, Progressive Multifocal in 1 studies

Leukoencephalopathy, Progressive Multifocal: An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stahl, NI1

Other Studies

1 other study available for dapsone and Leukoencephalopathy, Progressive Multifocal

ArticleYear
Progressive multifocal leukoencephalopathy in a minimally immunosuppressed patient with systemic lupus erythematosus treated with dapsone.
    The Journal of rheumatology, 2008, Volume: 35, Issue:4

    Topics: Dapsone; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Immu

2008